Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics Purchases Illumina HiSeq, BeadXpress


This article was orignally published Aug. 25.

Ambry Genetics has acquired an Illumina HiSeq 2000 sequencer for its service business, along with an Illumina BeadXpress genotyping system.

The HiSeq will allow the Aliso Viejo, Calif.-based firm "to run large projects for its customers while saving costs and providing the fastest turnaround times for sequencing," according to a company statement. Ambry has provided sequencing services on the Illumina Genome Analyzer since 2007.

Ambry, which has a CAP-accredited and CLIA-certified clinical laboratory, offers both genomic services and genetic diagnostic and carrier testing.

An Illumina-certified service provider, it currently provides a variety of sequencing services on the GAIIx, including whole-genome sequencing, exome sequencing, and RNA sequencing. For targeted sequencing, the company uses the Agilent SureSelect, RainDance, and Roche NimbleGen enrichment methods.

This spring, Ambry said it was working on a sequencing-based genetic carrier screening test to assay known mutations involved in more than 90 genetic diseases (IS 5/18/2010).

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.